Navigation Links
DIA Conference to Explore The Science and Scope of Personalized Medicine
Date:9/1/2009

The Drug Information Association (DIA) will host Personalized Medicine: Biomarkers and Diagnostics in Drug Development, Regulatory Approval, and Access to Patients from October 15-16, 2009 in Toronto, Ontario, Canada.

Horsham, PA (Vocus) September 1, 2009 -- The Drug Information Association (DIA) will host Personalized Medicine: Biomarkers and Diagnostics in Drug Development, Regulatory Approval, and Access to Patients from October 15-16, 2009 in Toronto, Ontario, Canada.

Speakers from academia, industry, regulatory agencies and patient groups will discuss the needs and opportunities from their specific points of view and explore the scope, science and medical elements of personalized medicine that can be used as indicators of disease diagnosis, progression, treatment and prognosis and would allow for a better targeting of the right therapies for patients. Sessions will include:

 
  • Personalized Medicine: Definition and Examples: Impact on Drug Development, Research and Development and Innovation
  • What are the Biomarkers?
  • What are the Diagnostics (Molecular, Genomics, Imaging, Point of Care, Immunology)?
  • Regulatory Considerations
  • Policy Considerations
  • Translation to Clinical Delivery
  • Prescriber and Patient Perspective
  • View on the Future Value to Canadians and the Healthcare Systems and Next Steps
"Canada has the opportunity to be an international leader in personalized medicine and needs to invest in this area for the health of Canadians, explains Program Co-chair Agnes V. Klein, MD, DRPH, Director, Center for Evaluation of Radiopharmaceuticals and Biotherapeutics, BGTD, HPFB, Health Canada."

Click here to register.

Click here to view program for the upcoming 7th Canadian Annual Meeting to be held November 3-4, 2009 in Ottawa, Ontario, Canada.

About the Drug Information Association (DIA):
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

Contact:
Joe Krasowski
DIA
+1-215-293-5812

###

Read the full story at http://www.prweb.com/releases/2009/09/prweb2819544.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
5. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
7. AtriCure to Present at Roth Capital Partners 2007 New York Conference
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. MDS to Present at Thomas Weisel Partners Healthcare Conference
10. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
11. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DIA Conference to Explore The Science and Scope of Personalized Medicine 
(Date:10/13/2017)... ... 13, 2017 , ... ProVest Insurance Group, a family managed ... Raleigh regions, is organizing an extended charity drive to benefit the family of ... , After struggling since birth with several health challenges, T.J. was later diagnosed ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... 13, 2017 , ... Lori R. Somekh, founder of the Law Office ... of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office ... forum to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... http://www.rebound-solution.com/ ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology: